Embolization is a minimally invasive procedure that blocks blood flow to a particular area of the body, leading to effective shrinkage of an aneurysm or a tumor.
Global Embolization Particles Market: Introduction
Embolization is a minimally invasive procedure that blocks blood flow to a particular area of the body, leading to effective shrinkage of an aneurysm or a tumor. The procedure is also used to treat various types of hemorrhages, cancerous tumors, as well as management of malignant hypertension caused due to renal failure.
Read Report Overview - https://www.transparencymarketresearch.com/embolization-particles-market.html
Carried out by interventional radiologist, the procedure is considered an alternative to open surgery. The procedure involves introduction of emboli for selectively occluding blood vessels. Embolization procedures are carried out by interventional radiologists.
Key Drivers of Global Embolization Particles Market
Increase in Incidence of Cancer
According to Cancer Research UK, 363,484 new cases of cancer were reported in the U.K. in 2014–2016. More than half of the new cases were breast, prostate, lung, or bowel cancers. Moreover, 85-89 years was the peak rate of cancer cases during 2014-2016. Breast, prostate, lung, and bowel cancers together accounted for over half (53%) of all the new cancer cases in the U.K. in 2016. Thyroid and liver cancers have shown the fastest increase in incidence in both males and females in the last decade in the U.K. Incidence of kidney cancer, melanoma skin cancer, and head & neck cancers has also increased in females in the last decade in the country.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46395
Rise in Prevalence of Lymphoma & Myeloma Cancers
Multiple myeloma is the third most common form of hematological malignancy after non-Hodgkin’s lymphoma and leukemia and is characterized by uncontrolled proliferation of a clone of plasma cells within the bone marrow. According to the Leukemia & Lymphoma Society (LLS), around 176,200 people in the U.S. are expected to be diagnosed with leukemia, lymphoma, or myeloma in 2019.
New cases of leukemia, lymphoma, and myeloma are anticipated to account for 10% of the estimated 1,762,450 new cancer cases diagnosed in the U.S. in 2019. An estimated 1,399,180 people in the U.S. are either living with, or are in remission from leukemia, lymphoma, or myeloma.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=46395
North America to Account for Major Share of Global Embolization Particles Market
North America is projected to account for major share of the global embolization particles market during the forecast period. This is attributed to the presence of major players in the region. Most of the key players operating in North America have made a series of strategic acquisitions, which have contributed to the increase in their market share. Rise in cancer prevalence is a key factor contributing to the growth of the market in the region.
According to the American Cancer Society, over 1,658,370 new cancer cases were diagnosed and 589,430 cancer deaths reported in the U.S. in 2015. Well-established reimbursement policies by private and public organizations is a major factor boosting the adoption of these devices in the region.
Pre Book Embolization Particles Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=46395<ype=S
Key Players Operating in Global Embolization Particles Market
The global embolization particles market is highly consolidated owing to the presence of small number of key players. Leading players operating in the global embolization particles market are:
- Abbott Laboratories
- Boston Scientific Corporation
- BTG plc
- Cook Medical, Inc.
- Edwards Lifesciences
- Johnson & Johnson
- Pfizer, Inc.
- Sirtex Medical Limited
- St. Jude Medical, Inc.
- Terumo Corporation
Browse More Trending Reports by Transparency Market Research:
Metabolism Drugs Market: https://www.transparencymarketresearch.com/metabolism-drugs-market.html
Automated Endoscopy Reprocessor Market: https://www.transparencymarketresearch.com/automated-endoscopy-reprocessor-market.html
Nicotine Replacement Therapy Market: https://www.transparencymarketresearch.com/nicotine-replacement-therapy-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/